DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Dalerba P. et al.
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
N Engl J Med 2016;
374: 211-222
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.